Patent ID: 7456211

Claim:
A compound according to formula (I): wherein R1 is selected from the group consisting of: C 1-6 alkyl, —C 1-2 alkylAr, and Ar; R2 is selected ftrom the group consisting of hydrogen, C 1-6 alkyl, —(CH 2 ) m OH, —(CH 2 ) n Ar′, —SO 2 R3, —C(O)R3, —C(O)NHR3, —C(O)OR3, —CH(R4)CONR5R6, and —CH(R4)CO 2 R7; R3 is selected from the group consisting of C 1-6 alkyl, —C 1-2 alkylAr′, and Ar′; R4 is hydrogen or C 1-6 alkyl; R5 and R6 are independently selected from the group consisting of hydrogen and C 1-6 alkyl; R7 is selected from the group consisting of hydrogen and C 1-3 alkyl; Ar is selected from the group consisting of phenyl, furyl, and thienyl, all of which may be optionally substituted by one or more Z 1 groups; Ar′ is selected from the group consisting of phenyl, naphthyl, furyl, pyridyl, thienyl, thiazolyl, isothiazolyl, pyrazolyl, triazolyl, tetrazolyl, imidazolyl, imidazolidinyl, benzofuranyl, indolyl, thiazolidinyl, isoxazolyl, oxadiazolyl, thiadiazolyl, morpholinyl, piperidinyl, piperazinyl, pyrrolyl, and pyrimidyl, all of which may be optionally substituted by one or more Z 2 groups; Z 1 is independently selected from the group consisting of hydrogen, C 1-3 alkyl, —CN, F, Cl, Br, and I; Z 2 is independently selected from the group consisting of hydrogen, C 1-6 alkyl, C 1-6 alkoxy, —(CH 2 ) n CO 2 R4, —C(O)NR5R6, —CN, —(CH 2 ) n OH, —NO 2 , F, Cl, Br, I, —NR5R6, and —NHC(O)R1; m is 2 to 5; and n is 0 to 5; or a pharmaceutically acceptable salt thereof.